Medicenna Therapeutics Corp - ESG Rating & Company Profile powered by AI
Complete ESG assessment of Medicenna Therapeutics Corp can be accessed by signing in. This webpage is a free Sustainability assessment covering Medicenna Therapeutics Corp. The assessment of Medicenna Therapeutics Corp uses data from across the internet and also from public documents by Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.7; made up of an environmental score of 8.0, social score of 3.2 and governance score of 6.0.
5.7
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 541 | Wntresearch AB | 5.8 | High |
| 541 | Zenotech Laboratories Ltd | 5.8 | High |
| 579 | Medicenna Therapeutics Corp | 5.7 | High |
| 579 | Caplin Point Laboratories Ltd | 5.7 | High |
| 579 | Biotest AG | 5.7 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Medicenna Therapeutics Corp have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Medicenna Therapeutics Corp disclose current and historical energy intensity?
Sign up for free to unlockDoes Medicenna Therapeutics Corp report the average age of the workforce?
Sign up for free to unlockDoes Medicenna Therapeutics Corp reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Medicenna Therapeutics Corp disclose its ethnicity pay gap?
Sign up for free to unlockDoes Medicenna Therapeutics Corp disclose cybersecurity risks?
Sign up for free to unlockDoes Medicenna Therapeutics Corp offer flexible work?
Sign up for free to unlockDoes Medicenna Therapeutics Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Medicenna Therapeutics Corp disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Medicenna Therapeutics Corp conduct supply chain audits?
Sign up for free to unlockDoes Medicenna Therapeutics Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Medicenna Therapeutics Corp conduct 360 degree staff reviews?
Sign up for free to unlockDoes Medicenna Therapeutics Corp disclose the individual responsible for D&I?
Sign up for free to unlockDoes Medicenna Therapeutics Corp disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Medicenna Therapeutics Corp disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Medicenna Therapeutics Corp disclose water use targets?
Sign up for free to unlockDoes Medicenna Therapeutics Corp have careers partnerships with academic institutions?
Sign up for free to unlockDid Medicenna Therapeutics Corp have a product recall in the last two years?
Sign up for free to unlockDoes Medicenna Therapeutics Corp disclose incidents of discrimination?
Sign up for free to unlockDoes Medicenna Therapeutics Corp allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Medicenna Therapeutics Corp issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Medicenna Therapeutics Corp disclose parental leave metrics?
Sign up for free to unlockDoes Medicenna Therapeutics Corp disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Medicenna Therapeutics Corp disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Medicenna Therapeutics Corp disclose the pay ratio of women to men?
Sign up for free to unlockDoes Medicenna Therapeutics Corp support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Medicenna Therapeutics Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Medicenna Therapeutics Corp reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Medicenna Therapeutics Corp involved in embryonic stem cell research?
Sign up for free to unlockDoes Medicenna Therapeutics Corp disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Medicenna Therapeutics Corp disclose its waste policy?
Sign up for free to unlockDoes Medicenna Therapeutics Corp report according to TCFD requirements?
Sign up for free to unlockDoes Medicenna Therapeutics Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Medicenna Therapeutics Corp disclose energy use targets?
Sign up for free to unlockDoes Medicenna Therapeutics Corp disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Medicenna Therapeutics Corp have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Medicenna Therapeutics Corp
These potential risks are based on the size, segment and geographies of the company.
Medicenna Therapeutics Corp., a clinical stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase 2b clinical trial for the treatment of recurrent glioblastoma (rGBM), as well as preclinical and clinical development stages for the treatment of other brain and non-brain tumors. The company also develops MDNA55, which has completed Phase 2b clinical trial to treat rGBM; MDNA109, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease (GvHD); MDNA413, a dual IL-4/IL-13 antagonist to treat solid tumors; and MDNA132, an IL-13 Superkine to chimeric antigen receptor T (CAR-T) platform. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, antibodies, or naked IL-2, IL-4, and IL-13 Superkines. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.